Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Acne Vulgaris - Treatment Options for Acne Patients Post Accutane's Withdrawal From US Market
Anxiety Disorders - Study Showed VYVANSE® (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment
Generics - FDA Accepts Tris Pharma's ANDA with Paragraph IV Certification for a Generic Equivalent to Delsym
Humanetics Corporation - Safety and Cognitive Stability Are Key Findings in Phase IIA Trial of New Alzheimer's Disease Treatment from Humanetics Corporation
Medicare and Medicaid - Endoscopic Technologies to Pay U.S. $1.4 Million to Resolve Allegations of Medicare Fraud
Pharmaceuticals - Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)
Universal Detection Technology - Department of Homeland Security Certifies Universal Detection Technology's Handheld Biodetection Kits for Counter-Terrorism
Abraxis BioScience, Inc. - CORRECTING and REPLACING Abraxis BioScience Completes Enrollment of Pivotal Phase III Advanced Lung Cancer Study Evaluating ABRAXANE® Vs. Taxol®
Accumetrics - Accumetrics' VerifyNow(R) P2Y12 Test Provides Physicians With Information to Assess a Patient's Response to Newly-Approved Prasugrel (Effient(R))
Centric Health Resources, Inc. - Centric Health Resources Presents Second Annual Ultra Orphan Conference 2009, "Emerging Commercialization Strategies for Addressing the Needs of Ultra Orphan Patients"
Clinical Research - DaVita Clinical Research Appoints Mahesh Krishnan as Vice President
Clinical Trial Research - Great Basin Scientific, Inc. Raises $3.6 Million In Bridge Funding To Prepare for First Product Launch
Clostridium - Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection
Contact Lens - Research on contact lens published by scientists at University of New South Wales
Cook Medical - Cook Medical Announces FDA Clearance for Advance® 35LP PTA Balloon Dilatation Catheter
Cutaneous T-Cell Lymphoma - Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clerazide for Treatment of Cutaneous T-Cell Lymphoma
CynerGreen, Llc - Concern Over Bottled Water Spawns New Miracle Filter and Merger
Cytori Therapeutics - Cytori's Celution® 700 System to be Regulated as a Medical Device by U.S. FDA
Daniel Ronel, M.D. - Dr. Daniel Ronel Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
Dermatology - Integrative Dermatology of Boca Raton Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
Dermatology & Cosmetic Skin Surgery - Dr. Benjamin Raab of Naperville, IL Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
Diabetes - Expert Statement Issued about Lantus(R) Following Recent Publications in Diabetologia
Diabetes - FDA Approves NovoLog(R) Labeling Update
Diagnostics - Magellan Diagnostic Businesses to Feature Automated Systems and Diagnostic Tests at Clinical Lab Expo
DNA Research - New findings in DNA research described by W.H. Ang and co-researchers
Dr. Frank P. Fechner - Facial Plastic Surgeon Dr. Frank Fechner Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
Escherichia Coli - Reports on Escherichia coli findings from Washington University, Medical Department provide new insights
Escherichia Coli - Research on Escherichia coli reported by scientists at University of Nebraska
Exocrine Pancreatic Insufficiency - Solvay Pharmaceuticals, Inc. Announces Commercial Availability of CREON(R) (Pancrelipase) Delayed-Release Capsules First and only FDA-approved therapy for exocrine pancreatic insuf
Female Infertility - GONAL-f Approved in Japan for Ovulation Induction in Infertile Women
Flu Vaccines - Influenza Monitoring by the US Military: Program Provides Important Data to Support Worldwide Health Efforts
FUJIFILM Dimatix, Inc. - FUJIFILM Dimatix Inkjet Printer Aids Researchers in Developing Paper-based Biosensors to Detect Toxins
Gas Chromatography - New findings from Agricultural University describe advances in gas chromatography
Gaucher Disease - Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Gene Therapy - Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks
Generics - Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel(R)
Hantavirus Epidemiology - Recent findings from Slovak Academy of Sciences highlight research in hantavirus epidemiology
Hearing Loss - Cochlear Americas Announces FDA Clearance of the Cochlear(TM) Baha(R) BP100 Sound Processor, the Industry's First Programmable Bone Conduction Hearing Solution
Heart Attack - FDA Approves Boston Scientific's TAXUS(R) Liberte(R) Long Stent
Heart Disease - Philips and Project Hope Announce Collaboration To Improve Chronic Disease Management In China
Hemochromatosis - Leading Blood Centers, LifeSource and Central Blood Bank, Spotlight a Unique Donor Population During National Hereditary Hemochromatosis Awareness Month
HIV/AIDS - Ugandan Medical Male Circumcision Program Launched to Prevent HIV Transmission
HST Global, Inc. - HST Global Announces Termination of Letter Agreement
Hyperuricemia - Marketing Authorization Granted by KFDA for TMX-67, Chronic Management of Hyperuricemia in Patients with Gout
iGuard.org - iGuard.org Expands Reach of Medication Safety Alerts and Recalls to Microsoft HealthVault Members
Immunization - Investigators at Emory University release new data on immunization
Insulin Pumps - OneTouch(R) Ping(TM) Glucose Management System Approved by Health Canada
IVAX Diagnostics, Inc. - IVAX Diagnostics, Inc. Increases Product Line Through Amended Agreement with IMMCO Diagnostics
Legionnaire Disease - Study findings from P. Aurass et al broaden understanding of legionnaire disease
Legionnaire Disease Cell Biology - Data on legionnaire disease cell biology detailed by researchers at Tel-Aviv University, George S. Wise Faculty of Life Sciences
Legionnaire Disease Therapy - New legionnaire disease therapy study findings have been reported by I. Almahmoud and co-researchers
Life Sciences - Research from Aichi Prefectural Institute of Public Health reveals new findings on life sciences
Life Sciences - Research on life sciences published by scientists at University of Southern California, Norris Comprehensive Cancer Center
Life Sciences - Researchers from National Institute for Occupational Safety and Health publish new studies and findings in the area of life sciences
Life Sciences - Studies from H. Poras and co-authors have provided new information about life sciences
Life Sciences - Study findings from Health Protection Agency Center for Infections provide new insights into life sciences
Maxygen, Inc. - Maxygen Announces Positive Results of MAXY-G34 Phase IIa Study in Breast Cancer Patients
Medtronic, Inc. - Medtronic Files Pre-Market Approval Application for FDA Approval of Deep Brain Stimulation for Treatment-Resistant Epilepsy
Mentor Capital, Inc. - Mentor Capital, Inc. Acquires 20% of Cutting Edge Cancer Immunotherapy Company: Quantum Immunologics, Inc.
Mentor Capital, Inc. - Quantum Immunologics, a Major Mentor Capital Investee, Starts FDA-Authorized Breast Cancer Trials
Merck & Co., Inc. - Merck and Schering-Plough Resolve Previously Disclosed Investigation Under State Consumer Protection Statutes Related to VYTORIN® ezetimibe/simvastatin and ZETIA® ezetimibe
Monoclonal Antibodies - New findings from St. Louis University describe advances in monoclonal antibodies
Monoclonal Antibodies - Research in the area of monoclonal antibodies reported from State University of New York
Motor Neuron Disease - Research from Z. Simmons and co-researchers in the area of motor neuron disease described
Myeloma Therapy - Research on myeloma therapy described by scientists at Princess Margaret Hospital
Naya Water - Naya Water: 50% Recycled Packaging, Bottles Now Have a Second Life
NeoStem, Inc. - NeoStem, Inc. Appoints Leading Chinese Medical Official to Its Advisory Board
Non-Small Cell Lung Cancer - ALIMTA(R) (pemetrexed for injection) First Agent Approved in Europe as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer
Nonin Medical, Inc. - Nonin Medical Announces FDA Clearance for its Next-Generation Regional Oximetry System
OSI Pharmaceuticals, Inc. and Genentech, Inc. - New Data from Phase III SATURN Study Showed Tarceva Improved Overall Survival When Used Immediately After Initial Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
Outcome Sciences, Inc. - Outcome to Lead First-Ever RFD Training Session at the 2009 CDISC Program Interchange Japan
ParagonRx - ParagonRx Files with FDA REMS Panel Interim Analysis for Opioid Drugs Study
Pediatrics - Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance(TM) for Treatment of Acute Pain and Fever
Phaeochromocytoma - National Institutes of Health publishes research in phaeochromocytoma
Pharmaceuticals - Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Libert (R) Long Stent
Pharmaceuticals - China Sky One Medical, Inc. Obtains Renewal of GMP Certificate
Pharmaceuticals - Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference
Pharmaceuticals - ParagonRx Creates New Website Featuring REMS Help Center for Pharma
Pharmaceuticals - Victory Pharma, Inc. Announces FDA Accepts MGX006 NDA for Review
Pharmaceuticals - Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
Prostate Cancer - New findings in prostate cancer described by O.B. Goodman and co-researchers
Prostate Cancer Therapy - Research on prostate cancer therapy discussed by scientists at NHS Foundation Trust
Public Health - Data from University of Sydney provide new insights into public health
Public Health - Reports on public health findings from Tehran University of Medical Sciences, School of Public Health and Institute of Public Health Research provide new insights
Pulmonology - Pulmonx Announces New President and CEO Michael A. Baker to Lead Interventional Pulmonology Company
Regulatory Actions - Avacor(R), Premier Provider of Hair Growth Solutions, Acquired By Investor Group.
Regulatory Actions - Bausch & Lomb Receives Approval of Crystalens HD in Quarter Diopter Steps
Regulatory Actions - Perrigo Receives FDA Approval to Market Cherry and Cinnamon Flavored Nicotine Lozenges
Regulatory Actions - University of North Carolina Doctor Receives National Institute of Health (NIH) Mentored Career Development Award
Salmonellosis - High Pressure Offers an Improved Method To Prepare Samples for the Detection of Food-Borne Pathogens
SigmaQuest Inc. - Stryker's Endoscopy Division Selects SigmaQuest SaaS for Supplier Quality Management
Smiths Detection - Smiths Detection Awarded $10.6 Million U.S. Government Contract for Advanced High-Energy X-Ray Systems
Thrombosis - Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)
Tuberculosis - Research from F. Laraque and co-researchers yields new findings on tuberculosis
Vaccine Efficacy - Econiche(TM) Vaccine Efficacy Summarized in July Issue of Foodborne Pathogens and Disease
Vein & Cosmetic Center of Tampa Bay - Vein & Cosmetic Center of Tampa Bay Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
Weight Loss - Wynonna Judd Celebrates Her Progress on alli With Private Concert at Legendary Venue
West Nile Virus - MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus
Research and Markets - Drug and Device Combination 2009-2014 - Current Market Has a Potential of US$10.6 Billion, a Growth of 15% CAGR over the Past Two Years
Research and Markets - New Report for the US Pharmaceutical Market with Outlook To 2014 - Latest Market Trends, Leading Players and Forecast Analysis
Research and Markets - With Ever-Evolving Best Practice and Guidelines on Leachables & Extractables, This Conference Was a One-Stop Source of Current Information on the Topic
Research and Markets Ltd. - This Essential Global Strategic Business Report on Bioterrorism Provides a Comprehensive Analysis and Annual Forecasts Through to 2015
